Source: Patient Worthy Challenges Unique to Cell and Gene Therapies (CGTx) Clinical Trials Cell and gene therapies (CGTx) have emerged as a novel and advanced
Source: PM360online Enhancing patient engagement in rare disease support programs requires tailored strategies that leverage innovative approaches, including AI and decentralized trials: Personalized Communication: Utilize
Source– BioProcess International The infusion of artificial intelligence (AI) technology in drug development has led to transformative solutions to age-old challenges, reshaping the trajectory from
Delays in clinical trials, worsened by the Inflation Reduction Act (IRA), are now a challenge to patient access to new therapies. Evolving complex regulatory requirements,
Source: PR Web President Biden’s loss of his beloved son to brain cancer in 2015 inspired the Cancer Moonshot initiative. Dr. Harsha Rajasimha’s inspiration for
Source: Telehealth and Medicine Today Clinical trials, the bedrock of medical research, are facing a pervasive challenge that threatens the very foundation of therapeutic development:
Source: Healthcare Business Today In the fast-evolving healthcare industry, the quest for innovative therapies is often hindered by formidable obstacles, chief among them being the
Source: HealthIT Answers The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede
Jeeva Clinical Trials Inc.
